Clinical Trial Update: Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study of LEO 43204 Gel in actinic keratosis under maximal-use conditions has completed, reporting PK data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• LEO 43204 Gel

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED